B

Bruker

Manufactures analytical instruments for NMR diagnostics

Accountant

Full-TimeDeadline 7/28/27
No salary listed
Mid
Bachelor's, Master's, MBA
Mumbai, Maharashtra, India
In Person
AccountingFinancial Accounting

About the job

Requirements
  • At least 3 years of work experience in statutory audits, tax audits, transfer pricing, customs, accounting, United States Generally Accepted Accounting Principles reporting, and direct and indirect taxation.
  • Deep understanding of Indian tax, statutory, and regulatory frameworks.
  • Prior experience working in an Indian subsidiary of a multinational corporation is preferred.
  • Strong working knowledge of United States Generally Accepted Accounting Principles.
  • Strong analytical skills with the ability to set priorities and meet deadlines.
  • Ability to handle multiple tasks and details effectively and manage non-negotiable timelines.
  • Ability to work independently with minimal supervision and follow processes and policies.
  • Strong interpersonal skills with the ability to gain the trust and confidence of finance and operational teams.
  • Advanced personal computer skills, including Microsoft Word and Microsoft Excel.
  • Fluency in spoken and written English.
  • High standards of ethics, integrity, and professionalism.
Responsibilities
  • Manage general accounting functions, including monthly, quarterly, and annual financial closings; accounts payable; accruals; fixed-asset management; group consolidation; management reporting; local statutory and regulatory reporting; and corporate reporting under United States and Indian Generally Accepted Accounting Principles.
  • Submit financial data and related reports to stakeholders accurately and on time.
  • Maintain internal accounting systems, manage enterprise resource planning data integrity, and oversee reconciliation processes.
  • Prepare direct and indirect tax filings, including Goods and Services Tax, Tax Deducted at Source, income tax, and transfer-pricing documentation, in collaboration with tax advisors and the Finance Manager.
  • Liaise with external tax consultants and support the Finance Manager with compliance involving Indian tax laws and regulatory changes.
  • Plan, drive, and manage assigned statutory, tax, and internal-control audits.
  • Support secretarial compliance for the Indian entity, including preparing board resolutions, ensuring Registrar of Companies filings, supporting board meetings, and maintaining statutory registers under the Companies Act.
  • Support Reserve Bank of India compliance filings and customs-related compliance, including Special Valuation Branch matters.
  • Coordinate compliance management with external tax consultants and other stakeholders.
  • Collaborate across departments and business-partner with business units to provide financial support and guidance and maintain financial transparency.
  • Identify and implement process improvements to enhance efficiency and compliance.
  • Maintain strong internal controls to prevent errors, fraud, and regulatory breaches.
  • Handle intercompany billing, payments, reconciliations, follow-up, and compliance.
  • Perform other assigned duties.
Desired Qualifications
  • B.Com, M.Com, CA Intermediate, or Master of Business Administration in Finance or an equivalent qualification.
  • Experience working in an Indian subsidiary of a multinational corporation, preferably a United States multinational corporation.
  • Experience with SAP enterprise resource planning, preferably SAP HANA.
  • Ability to work as a strong team player.
  • Results-oriented and business-focused approach.
  • Self-starting approach with strong organizational and problem-solving skills.

About the company

Bruker makes analytical and diagnostic instruments used by researchers and industries. Its products help analyze materials and biological samples to reveal chemical structure, composition, and properties, with notable roots in nuclear magnetic resonance (NMR) technology and a broad portfolio beyond that field. The company works by designing and selling instruments such as analytical tools that collect data from samples (for example, signals from nuclei in NMR or other spectroscopic methods) and provide insights to researchers. Bruker differentiates itself through a long history of developing advanced technologies, a focus on innovation in scientific instrumentation, and a global product range serving life sciences, materials science, and environmental analysis, supported by steady investment in research and development. Its goal is to equip researchers and industries with reliable tools to push the boundaries of what is possible in science and discovery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 28, 2026 timsUltra AIP and timsOmni launches deepen proteomics and oligonucleotide workflows.
  • August 10, 2026 MIMETAS deal expands Bruker into human-relevant drug discovery models.
  • UC Berkeley ordered over $6 million of Bruker NMR systems, delivering 2027 revenue.

What critics are saying

  • Bruker’s first-half 2026 organic revenue declined 0.8%, exposing fragile demand recovery.
  • Academic spending stayed soft in 2026, while tariffs and currency pressured results.
  • If MIMETAS and fusion remain niche, Bruker’s acquisition-heavy strategy destroys capital returns.

What makes Bruker unique

  • Bruker owns timsTOF proteomics, NMR, microscopy, and microphysiological systems under one platform.
  • Bruker’s August 31 XFlash 7200 FIRE raises SEM-EDS throughput beyond conventional detector designs.
  • Bruker’s BEST superconductors supply ITER, Wendelstein 7-X, CERN, and fusion demonstrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Disability Insurance

Life Insurance

Dental Insurance

Flexible Work Hours

Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

13%

2 year growth

13%
Business Wire
Oct 14th, 2026
Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools...

Financial Times
Sep 28th, 2026
Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research. Sep 28 2026 12:00 BST * MultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP * ProteoScape connects PASEF discovery with rapid prm-PASEF target validation * Spectronaut(R) AI transfer learning accelerates adaptation to new MS capabilities * Guided PASEF EXciD enables high-throughput glycopeptide characterization * Integrated HDX-MS workflows advance protein conformation and interaction studies * timsOmni(TM) enables RNA and DNA top-down structural and native RNA analysis SINGAPORE-(BUSINESS WIRE)-Sep. 28, 2026- At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF discovery with prm-PASEF target validation on the same timsTOF platform. Novel timsOmni and integrated HDX-MS workflows extend structural analysis to glycopeptides, proteins, and nucleic acids.

MarketScreener
Sep 21st, 2026
Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure.

Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure. Published on 09/21/2026 at 09:36 am EDT S&P Capital IQ Bruker Corporation announced a multi-system order from University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz?class instrumentation. The investment is centered on a Bruker AV NEO-X 800 MHz spectrometer equipped with a cryogenically cooled MAS CryoProbe, complemented by several additional NMR systems and upgrades supporting solid-state, solution-state and Dynamic Nuclear Polarization (DNP) research. The UC Berkeley NMR order exceeds USD 6 million and is expected to be delivered in 2027. (C) S&P Capital IQ - 2026

U.S. Securities and Exchange Commission
Sep 19th, 2026
10-K

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

U.S. Securities and Exchange Commission
Sep 18th, 2026
10-Q

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023